Intercept Pharmaceuticals (ICPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,643 | -12,738 | -15,087 | N/A | N/A |
| Depreciation Amortization | 320 | 411 | 480 | N/A | N/A |
| Other Working Capital | -592 | 13,895 | -71 | N/A | N/A |
| Other Operating Activity | 28,166 | 1,038 | 1,020 | 0 | 0 |
| Operating Cash Flow | $-15,750 | $2,606 | $-13,658 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 3 | -3 | 87 | N/A | N/A |
| PPE Investments | -39 | -63 | -29 | N/A | N/A |
| Purchase Of Investment | -65,941 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 1,119 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-64,857 | $-66 | $58 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -82 | -250 | -270 | N/A | N/A |
| Common Stock Issued | 108,500 | N/A | 24,888 | N/A | N/A |
| Financing Cash Flow | $108,418 | $-250 | $24,618 | $N/A | $N/A |
| Exchange Rate Effect | -7 | -6 | -29 | N/A | N/A |
| Beginning Cash Position | 17,708 | 15,424 | 4,435 | N/A | N/A |
| End Cash Position | 45,512 | 17,708 | 15,424 | N/A | N/A |
| Net Cash Flow | $27,804 | $2,284 | $10,989 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,750 | 2,606 | -13,658 | N/A | N/A |
| Capital Expenditure | -39 | -63 | -29 | N/A | N/A |
| Free Cash Flow | -15,788 | 2,543 | -13,687 | 0 | 0 |